Jasper van Grunsven Files Initial Form 3 for Vertex Pharmaceuticals ($VRTX)
VERTEX PHARMACEUTICALS INC / MA
Subscribe to track VRTX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Initial Statement of Beneficial Ownership (Form 3) Issuer: Vertex Pharmaceuticals Inc. ($VRTX) Insider: Jasper van Grunsven (EVP, CP and NPPO) Date of Event: September 8, 2026 Securities Owned: 0 shares Significance: Low (Initial filing, no securities owned)
Comprehensive Analysis
Executive Summary
On September 10, 2026, Jasper van Grunsven filed an initial Form 3 with the SEC disclosing their status as an insider of Vertex Pharmaceuticals Inc. ($VRTX) as of September 8, 2026. Mr. van Grunsven serves as Executive Vice President, CP and NPPO.
Holdings & Transactions
- Form Type: Form 3 (Initial Statement of Beneficial Ownership)
- Reported Ownership: No securities are beneficially owned at this time (
<noSecuritiesOwned>1</noSecuritiesOwned>). - Remarks: Filing includes Exhibit 24 (Power of Attorney).
Market Impact & Significance
This filing represents a standard initial ownership disclosure upon assuming an officer role or becoming subject to Section 16 reporting requirements. Because no direct open-market transactions or equity holdings are reported, the market significance is deemed Low.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.